CLINICAL_TRIALS
trial_result
· 2018-01-09
Clinical Trial Update: Preventing Cholestasis Using SMOFLipid® [Phase 4]
Summary
Phase 4 clinical trial update evaluating SMOFLipid for preventing cholestasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Vienna | Conditions: Cholestasis, Psychomotor Disorders, Developmental | Phase 4 | Status: COMPLETED